BluePrintยฎ Identifies Genomic Subtypes for African-American Breast Cancer Patients with Low Risk Outcomes
PRESS RELEASE New data presented at ASCO underscores importance of Read More
PRESS RELEASE New data presented at ASCO underscores importance of Read More
PRESS RELEASE IRVINE, CALIF., U.S., and AMSTERDAM, NETHERLANDS โ 31 Read More
PRESS RELEASE IRVINE, CALIF., U.S., and AMSTERDAM, NETHERLANDS โ 21 Read More
PRESS RELEASE ER+ breast cancer patients reclassified as ER+ Read More
PRESS RELEASE Simultaneous creation of Global Lab Center of Excellence Read More
PRESS RELEASE Determination finds that Agendiaโs MammaPrintยฎ Breast Cancer Risk Read More
PRESS RELEASE New Studies Show MammaPrintยฎ and BluePrintยฎ Tests Provide Read More
PRESS RELEASE Agendia Announces New Research Reinforcing MammaPrintยฎ and BluePrintยฎ Read More
PRESS RELEASE Oncology Consultants Join Agendiaโs FLEX Big DataRegistry Study, Read More
ย PRESS RELEASE Latest Results from the I-SPY 2 Trial at Read More